NICHOLE MARTIN: Open Payments
NPI 1629001565 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 38 payments from 14 companies in 2025. Trend: 2023 $125 · 2024 $126 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $167 |
| Lilly USA, LLC | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| PFIZER INC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Organogenesis Inc. | 1 | $46 |
| Exact Sciences Corporation | 2 | $36 |
| Amgen Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: MOUNJARO, Wegovy, TRINTELLIX, JARDIANCE, PURAPLY WOUND MATRIX, ELIQUIS, Cologuard Collection Kit, OTEZLA.
Industry payments across MD — which companies pay providers there.
